Detalles de la búsqueda
1.
Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin.
Clin Infect Dis
; 76(3): e910-e919, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861296
2.
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin.
Antimicrob Agents Chemother
; 67(11): e0043123, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850737
3.
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin.
Antimicrob Agents Chemother
; 67(11): e0043023, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850738
4.
Understanding the Role of Past Health Care Discrimination in Help-Seeking and Shared Decision-Making for Depression Treatment Preferences.
Qual Health Res
; 30(12): 1833-1850, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32713258
5.
Community Health Workers Improve HIV Disclosure Among HIV-Affected Sexual Partners in Rural Uganda: A Quasi-Experimental Study.
Glob Health Sci Pract
; 10(5)2022 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316143
6.
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF).
Trials
; 21(1): 181, 2020 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32054536
7.
Knowledge, Attitudes, and Perceived Risks Related to Diabetes Mellitus Among University Students in Uganda: A Cross-Sectional Study.
East Afr Health Res J
; 1(2): 105-112, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29250612
Resultados
1 -
7
de 7
1
Próxima >
>>